| P50 | author | Peter John Sadler | Q21165174 |
| | Pingyu Zhang | Q57034262 |
| | Cinzia Imberti | Q58522338 |
| | Huaiyi Huang | Q68695388 |
| P2093 | author name string | Cinzia Imberti | |
| P2860 | cites work | Recent Advances in the Design of Targeted Iridium(III) Photosensitizers for Photodynamic Therapy | Q90305724 |
| | Titanium-Based Nanoscale Metal-Organic Framework for Type I Photodynamic Therapy | Q91700958 |
| | A tumor-targeting Ru/polysaccharide/protein supramolecular assembly with high photodynamic therapy ability | Q91879364 |
| | Photoactivatable platinum anticancer complex can generate tryptophan radicals | Q93366239 |
| | Metal Drugs and the Anticancer Immune Response | Q93389316 |
| | Hypoxia and metabolic adaptation of cancer cells | Q26774856 |
| | Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy | Q27004011 |
| | The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs | Q28066801 |
| | Reactive species formed on proteins exposed to singlet oxygen | Q28240610 |
| | Complications of whole bladder dihematoporphyrin ether photodynamic therapy | Q28341915 |
| | Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT. | Q33437363 |
| | Iron and cancer: more ore to be mined | Q33677592 |
| | Inhibition of cathepsin activity in a cell-based assay by a light-activated ruthenium compound | Q33893128 |
| | Trans,trans,trans-[PtIV(N3)2(OH)2(py)(NH3)]: a light-activated antitumor platinum complex that kills human cancer cells by an apoptosis-independent mechanism. | Q33923112 |
| | From patient to discoverer--Niels Ryberg Finsen (1860–1904) --the founder of phototherapy in dermatology | Q34033028 |
| | Photocytotoxic trans-diam(m)ine platinum(IV) diazido complexes more potent than their cis isomers | Q34105902 |
| | De novo generation of singlet oxygen and ammine ligands by photoactivation of a platinum anticancer complex | Q34503145 |
| | Low-level light/laser therapy versus photobiomodulation therapy | Q35325034 |
| | Induction of immunogenic cell death by chemotherapeutic platinum complexes. | Q35601291 |
| | Nitric oxide release: part II. Therapeutic applications | Q35926097 |
| | A potent cytotoxic photoactivated platinum complex | Q36696320 |
| | Photorelease of GABA with Visible Light Using an Inorganic Caging Group | Q36936097 |
| | Ruthenium tris(2-pyridylmethyl)amine as an effective photocaging group for nitriles | Q37714170 |
| | Targeted delivery of platinum-based anticancer complexes | Q38080318 |
| | Photonic crystal fibres for chemical sensing and photochemistry. | Q38113461 |
| | Effects of light-activated diazido-PtIV complexes on cancer cells in vitro | Q38115290 |
| | Tumor-targeted photodynamic therapy | Q38115511 |
| | Photodynamic therapy: current status and future directions. | Q38211293 |
| | Photocontrolled DNA binding of a receptor-targeted organometallic ruthenium(II) complex | Q38333052 |
| | A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress | Q38713515 |
| | A ruthenium(ii) based photosensitizer and transferrin complexes enhance photo-physical properties, cell uptake, and photodynamic therapy safety and efficacy. | Q38788535 |
| | Cobalt(III) Chaperone Complexes of Curcumin: Photoreduction, Cellular Accumulation and Light-Selective Toxicity towards Tumour Cells | Q38827618 |
| | An integrin-targeted photoactivatable Pt(IV) complex as a selective anticancer pro-drug: synthesis and photoactivation studies | Q38878464 |
| | A novel class of ruthenium-based photosensitizers effectively kills in vitro cancer cells and in vivo tumors. | Q38911313 |
| | Optimizing the electronic properties of photoactive anticancer oxypyridine-bridged dirhodium(II,II) complexes | Q38936519 |
| | Cellular accumulation, lipophilicity and photocytotoxicity of diazido platinum(IV) anticancer complexes | Q38993842 |
| | A bis(dipyridophenazine)(2-(2-pyridyl)pyrimidine-4-carboxylic acid)ruthenium(II) complex with anticancer action upon photodeprotection. | Q39026748 |
| | Near-infrared light-mediated photoactivation of a platinum antitumor prodrug and simultaneous cellular apoptosis imaging by upconversion-luminescent nanoparticles. | Q39047691 |
| | Exploitation of long-lived 3IL excited states for metal-organic photodynamic therapy: verification in a metastatic melanoma model. | Q39078212 |
| | Tryptophan switch for a photoactivated platinum anticancer complex | Q39275827 |
| | In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers | Q39277632 |
| | Strained ruthenium complexes are potent light-activated anticancer agents | Q39354352 |
| | Interactions of DNA with a new platinum(IV) azide dipyridine complex activated by UVA and visible light: relationship to toxicity in tumor cells. | Q39379295 |
| | A fast ruthenium polypyridine cage complex photoreleases glutamate with visible or IR light in one and two photon regimes. | Q39512704 |
| | Studies on the photoactivation of two cytotoxic trans,trans,trans-diazidodiaminodihydroxo-Pt(IV) complexes | Q39565270 |
| | Influence of pyridine versus piperidine ligands on the chemical, DNA binding and cytotoxic properties of light activated trans,trans,trans-[Pt(N3)2(OH)2(NH3)(L)]. | Q39568240 |
| | Ground and excited state properties of photoactive platinum(IV) diazido complexes: theoretical considerations. | Q50531172 |
| | A Mitochondria-Targeted Photosensitizer Showing Improved Photodynamic Therapy Effects Under Hypoxia. | Q51496347 |
| | A Photoactive Platinum(IV) Anticancer Complex Inhibits Thioredoxin-Thioredoxin Reductase System Activity by Induced Oxidization of the Protein. | Q52311129 |
| | Nanoscale Metal-Organic Framework Overcomes Hypoxia for Photodynamic Therapy Primed Cancer Immunotherapy. | Q52582574 |
| | Achieving efficient photodynamic therapy under both normoxia and hypoxia using cyclometalated Ru(ii) photosensitizer through type I photochemical process. | Q52606012 |
| | Photoactivation of the Cytotoxic Properties of Platinum(II) Complexes through Ligand Photoswitching. | Q52654178 |
| | Designing hydrogels for controlled drug delivery. | Q55264903 |
| | Sequence-dependent attack on peptides by photoactivated platinum anticancer complexes. | Q55322316 |
| | Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433 | Q57180591 |
| | Near-Infrared Light-Initiated Molecular Superoxide Radical Generator: Rejuvenating Photodynamic Therapy against Hypoxic Tumors | Q58596356 |
| | Nucleus-Targeted Organoiridium-Albumin Conjugate for Photodynamic Cancer Therapy | Q62002029 |
| | Why develop photoactivated chemotherapy? | Q63888827 |
| | Toxicity and mutagenicity of sodium azide in mammalian cell cultures | Q71219575 |
| | Photodynamic therapeutics: basic principles and clinical applications | Q73102562 |
| | Dual anticancer activity in a single compound: visible-light-induced apoptosis by an antiangiogenic iridium complex | Q82367578 |
| | Photoreaction pathways for the anticancer complex trans,trans,trans-[Pt(N3)2(OH)2(NH3)2] | Q82454137 |
| | H2O2-activatable and O2-evolving nanoparticles for highly efficient and selective photodynamic therapy against hypoxic tumor cells | Q86502125 |
| | Photoactivatable cytotoxic agents derived from mitochondria-targeting luminescent iridium(III) poly(ethylene glycol) complexes modified with a nitrobenzyl linkage | Q87408480 |
| | Phthalocyanine-Assembled Nanodots as Photosensitizers for Highly Efficient Type I Photoreactions in Photodynamic Therapy | Q89174410 |
| | A potent trans-diimine platinum anticancer complex photoactivated by visible light. | Q39672784 |
| | A photoactivated trans-diammine platinum complex as cytotoxic as cisplatin | Q40318101 |
| | Light-activated destruction of cancer cell nuclei by platinum diazide complexes | Q40326818 |
| | WST11, a novel water-soluble bacteriochlorophyll derivative; cellular uptake, pharmacokinetics, biodistribution and vascular-targeted photodynamic activity using melanoma tumors as a model. | Q40476507 |
| | New platinum antitumor complexes | Q40732426 |
| | A Visible-Light-Sensitive Caged Serotonin | Q41536076 |
| | Mitochondria Targeted Protein-Ruthenium Photosensitizer for Efficient Photodynamic Applications | Q41614195 |
| | Traumatic Brain Injury Imaging in the Second Near-Infrared Window with a Molecular Fluorophore | Q41876512 |
| | A Red-Light-Activated Ruthenium-Caged NAMPT Inhibitor Remains Phototoxic in Hypoxic Cancer Cells. | Q41916219 |
| | Photoinduced reactions of cis,trans,cis-[Pt(IV)(N3)2(OH)2(NH3)2) with 1-methylimidazole. | Q42104859 |
| | Nucleotide cross-linking induced by photoreactions of platinum(IV)-azide complexes. | Q44291882 |
| | Eradication of HT-29 colorectal adenocarcinoma cells by controlled photorelease of CO from a CO-releasing polymer (photoCORP-1) triggered by visible light through an optical fiber-based device. | Q45963547 |
| | Hybrid TiO2 -Ruthenium Nano-photosensitizer Synergistically Produces Reactive Oxygen Species in both Hypoxic and Normoxic Conditions | Q46341936 |
| | To cage or to be caged? The cytotoxic species in ruthenium-based photoactivated chemotherapy is not always the metal | Q46353606 |
| | Effect of ring methylation on the photophysical, photochemical and photobiological properties of cis-dichlorobis(1,10-phenanthroline)rhodium(III)Chloride | Q46474133 |
| | Endoplasmic Reticulum-Localized Iridium(III) Complexes as Efficient Photodynamic Therapy Agents via Protein Modifications | Q46505901 |
| | Photorelease and Cellular Delivery of Mitocurcumin from Its Cytotoxic Cobalt(III) Complex in Visible Light. | Q46539910 |
| | A highly selective luminescent switch-on probe for histidine/histidine-rich proteins and its application in protein staining | Q46645093 |
| | The cis-Diammineplatinum(II) Complex of Curcumin: A Dual Action DNA Crosslinking and Photochemotherapeutic Agent | Q46662167 |
| | Liposome encapsulation of a photochemical NO precursor for controlled nitric oxide release and simultaneous fluorescence imaging | Q46675971 |
| | Unprecedented carbon-carbon bond formation induced by photoactivation of a platinum(IV)-diazido complex | Q46842262 |
| | Organoiridium Photosensitizers Induce Specific Oxidative Attack on Proteins within Cancer Cells. | Q47097205 |
| | Red Light-Triggered CO Release from Mn2(CO)10 Using Triplet Sensitization in Polymer Nonwoven Fabrics. | Q47141492 |
| | Molecular photosensitisers for two-photon photodynamic therapy. | Q47370653 |
| | Critical Overview of the Use of Ru(II) Polypyridyl Complexes as Photosensitizers in One-Photon and Two-Photon Photodynamic Therapy. | Q47603787 |
| | Continuous O2-Evolving MnFe2O4 Nanoparticle-Anchored Mesoporous Silica Nanoparticles for Efficient Photodynamic Therapy in Hypoxic Cancer. | Q47888891 |
| | Illuminating cytochrome P450 binding: Ru(ii)-caged inhibitors of CYP17A1. | Q48044713 |
| | Evaluation of the Medicinal Potential of Two Ruthenium(II) Polypyridine Complexes as One- and Two-Photon Photodynamic Therapy Photosensitizers | Q48137591 |
| | Overcoming the Limits of Hypoxia in Photodynamic Therapy: A Carbonic Anhydrase IX-Targeted Approach. | Q48212596 |
| | Supramolecular Photoactivatable Anticancer Hydrogels | Q48271205 |
| | Biodegradable MoOx nanoparticles with efficient near-infrared photothermal and photodynamic synergetic cancer therapy at the second biological window | Q50179147 |
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | metal | Q11426 |
| | transition metal | Q19588 |
| P1104 | number of pages | 13 | |
| P304 | page(s) | 61-73 | |
| P577 | publication date | 2019-09-24 | |
| | 2020-01-02 | |
| P1433 | published in | Angewandte Chemie International Edition | Q62023953 |
| P1476 | title | New Designs for Phototherapeutic Transition Metal Complexes | |
| P478 | volume | 59 | |